All lobbying filings

MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA)

MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA) filed a Q3 report for MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA) on October 19, 2026.

Lobbying for MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA) · Represents and protects the interests of midsized biopharmaceutical innovators.

All filings by MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA) · Everything MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA) has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Expenses

$300,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 1

ALANNA TEMME

Previously held: Legislative Director, U.S. Representative Jon Porter

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Pharmacy

Prescription drug payment reform. Pharmaceutical Supply Chain.

Medicare/Medicaid

General Medicare and Medicaid Issues.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.